RTW INVESTMENTS, LP

Q2 2023 13F-HR Holdings

Location
New York, NY
Holdings as of
6/30/2023
Date filed
8/14/2023
Form type
13F-HR
Num holdings
62
Total value ($000)
$5,252,749
Net value change ($000)
+450,596 (9.4%)
New positions
10
Sold out positions
8
Turnover %
14.0%
Sector allocation + QoQ delta (equities-only)

Holdings aggregated across other managers listed in the original SEC filing. View detailed breakdown

Snapshot: Change Analysis

Compared to Q1 2023
Methodology: sector metrics are equities-only; instrument mix chart is ex-options; options exposure is shown separately. Why this matters.
Top Adds (Value $000, Stocks/ETFs)
BRKR 125,164 133.7%
Horizon Therapeutics Public Ltd Co 102,850 NEW
IMCR 82,204 29.4%
ACAD 79,178 51.0%
RARE 78,070 45.6%
AXSM 74,665 32.0%
AVDL 59,643 113.4%
ISRG 58,130 NEW
MDGL 51,181 NEW
RCKT 48,464 16.0%
Top Reduces (Value $000, Stocks/ETFs)
Prometheus Biosciences, Inc. -351,162 -100.0%
OBIO -60,825 -60.7%
PTCT -49,344 -14.4%
VTYX -46,528 -100.0%
MASI -30,015 -10.8%
RNAM -23,853 -24.3%
NTRA -17,917 -12.4%
ALNY -17,473 -5.2%
ILMN -16,954 -19.4%
TMO -15,858 -9.5%
Instrument mix + QoQ Δ (ex-options)
How this table is calculated: SEC VALUE ($000) is used as reported. For derivatives (PUT/CALL/WARRANT/RIGHT), SEC value represents reported underlying exposure, not premium cash paid/received. Column % is bucket-based: non-options share is calculated inside non-option total, options share is calculated inside options total. Details.
Filter:
Instrument:
Issuer Name Ticker Sector Industry Class History Value ($000) % Shares Shares Δ Shares Δ% Value Δ ($000) Value Δ% Principal Option Type